Stability of benzylpenicillin for continuous intravenous infusions: An isotonic formulation for therapeutic use and a low-dose formulation for clinical trial-Reference-Cited by-同舟云学术

Stability of benzylpenicillin for continuous intravenous infusions: An isotonic formulation for therapeutic use and a low-dose formulation for clinical trial

Published:2022-09 Issue:9 Volume:28 Page:1225-1230
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Batty Kevin T.^ORCID,Page-Sharp Madhu^ORCID,Salman Sam^ORCID,Hla Thel K.^ORCID,Manning Laurens^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference33 articles.

1. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC);Habib;Eur Heart J,2015

2. Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis;Briggs;J Antimicrob Chemother,2021

3. Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy;Norris;Clin Infect Dis,2018

4. Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates;Perks;Eur J Hosp Pharm,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol for controlled human infection for penicillin G againstStreptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial);BMJ Open;2022-12